市场调查报告书

EPA浓缩型·藻类Omega-3脂肪酸的全球市场:成长·趋势·预测

EPA Focused Algae Omega-3 Ingredient Market - Growth, Trends And Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品编码 649817
出版日期 内容资讯 英文 100 Pages
商品交期: 2-3个工作天内
价格
EPA浓缩型·藻类Omega-3脂肪酸的全球市场:成长·趋势·预测 EPA Focused Algae Omega-3 Ingredient Market - Growth, Trends And Forecast (2020 - 2025)
出版日期: 2020年03月01日内容资讯: 英文 100 Pages
简介

本报告提供全球EPA (二十碳五烯酸) 浓缩型·藻类Omega-3脂肪酸的市场相关分析,提供产品概要·特性,及市场基本结构,主要的推动及阻碍市场要素,各浓度·不同形状·各用途·各地区的市场趋势预测,主要企业的简介,今后的投资机会/市场成长机会等调查。

第1章 简介

第2章 调查方法

第3章 摘要整理

第4章 市场动态

  • 推动市场要素
  • 阻碍市场要素
  • 波特的五力分析
    • 新加入企业的威胁
    • 买主/消费者谈判力
    • 供应商谈判力
    • 替代产品的威胁
    • 企业间竞争的激烈程度

第5章 市场区隔

  • 各浓度
    • 高浓度
    • 中浓度
    • 低浓度
  • 不同形状
    • 三酸甘油酯
    • 乙酯
  • 各用途
    • 食品·饮料
    • 营养补充品 (补充品)
    • 医药品
    • 饲料
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美
    • 中东·非洲

第6章 竞争情形

  • 最活跃的企业
  • 主要企业采用了的策略
  • 市场占有率分析
  • 企业简介
    • Koninklijke DSM N.V.
    • Omega Protein Corporation
    • The Archer Daniels Midland Company
    • Corbion N.V.
    • BASF SE
    • Pelagia AS
    • Golden Omega
    • Novotech Nutraceuticals, Inc.

第7章 市场机会·未来趋势

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 57066

The global EPA focused algae omega-3 ingredient market is growing at a CAGR of 8.2% during the forecast period (2020-2025).

Omega-3 oils are essential fatty acids that have a broad range of health benefits, including cardiovascular, eye and brain health, for which is it is widely used in the various end-user application, like dietary supplements, infant nutrition, functional food and beverages, and pharmaceutical and clinical nutrition.

The EPA market is majorly driven by robust demands from the dietary supplements sector wherein an increasing amount of EPA is channelized in developing adult-based essential omega-3 supplements. Also, its robust application in different sectors such as infant formula, dietary supplement, fortified food and beverages, animal nutrition, and pharmaceuticals have further fueled the global market growth.

However, few of the regulations from the regulatory bodies are the factors restraining the global market growth. For instance, according to the IEG (International Expert Group) recommendations, the content of EPA in infant formula should not exceed the DHA content, which is creating a barrier for key players who are willing to introduce EPA-based infant formula products.

Key Market Trends

Demand For EPA In Infant Formulae & Functional Food And Beverages To Drive The Market

The extensive use of EPA in combination for developing effective infant nutrition solutions and functional food and beverages is found to boost the global algae omega-3 ingredient market. The vast body of scientific evidence supporting the role of EPA in*infants' cognitive and visual development*has further fueled infant formulae in the global marketplace. For instance, a plethora of new research and clinical studies have conclusively demonstrated that low EPA and DHA is a strong risk factor for preterm birth. Also, many foods such as milk, yogurt, margarine, bread, and chocolates are found to be increasingly fortified with EPA as supplying of omega-3 fatty acids in the diet, through fortified foods are expected to effectively meet the body's metabolic needs, better than dietary supplements.

Asia Pacific To Witness The Fastest Growth In The Global Market

Asia- Pacific is the fastest-growing regions for the algae omega-3 ingredient market with major markets of India and Australia. The Indian EPA market is driven by rich fish biodiversity that acts as an ideal source and abysmally low level of EPA in Indian diets that necessitates its consumption through nutraceuticals. Also, the dietary supplements sector in the Indian marketplace is expected to emerge as a lucrative application sector for EPA ingredients amid an increase in discretionary spending. The favoring regulations imposed by the regulatory bodies have further fueled the market of the region. For instance, the National Heart Foundation of Australia recommends EPA in the range of 500-1200 mg per day for reducing the risk of cardiovascular diseases and hypertriglyceridemia.

Competitive Landscape

The global market for EPA focused algae omega-3 ingredient is fragmented, owing to the presence of a large number of regional and domestic players in different countries. Emphasis is given on the merger, expansion, acquisition, and partnership of the companies along with new product development as strategic approaches adopted by the leading companies to boost their brand presence among consumers. For instance, Croda International PLC, acquired Nautilus Biosciences Canada Inc., a marine biotechnology company based in Charlottetown, in 2018, so as to utilize its innovative science for applications across all Crodas' market sectors. Also, BASF Newtrition Omega-3 launched Accelon absorption-accelerating technology, to enable more omega-3's bioavailability in 2017.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Porters 5 Force Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Bargaining Power of Suppliers
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Concentration
    • 5.1.1 High concentration
    • 5.1.2 Medium concentration
    • 5.1.3 Low concentration
  • 5.2 By Form
    • 5.2.1 Triglycerides
    • 5.2.2 Ethyl esters
  • 5.3 By Application
    • 5.3.1 Food & Beverage
      • 5.3.1.1 Functional Food & Beverage
      • 5.3.1.2 Infant Formula
    • 5.3.2 Dietary Supplements
    • 5.3.3 Pharmaceuticals
    • 5.3.4 Animal Feed
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
      • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
      • 5.4.2.1 United Kingdom
      • 5.4.2.2 Germany
      • 5.4.2.3 France
      • 5.4.2.4 Russia
      • 5.4.2.5 Italy
      • 5.4.2.6 Spain
      • 5.4.2.7 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 India
      • 5.4.3.2 China
      • 5.4.3.3 Japan
      • 5.4.3.4 Australia
      • 5.4.3.5 Rest of Asia-Pacific
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East & Africa
      • 5.4.5.1 South Africa
      • 5.4.5.2 Saudi Arabia
      • 5.4.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Most Active Companies
  • 6.2 Strategies Adopted by Key Players
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles
    • 6.4.1 Koninklijke DSM N.V.
    • 6.4.2 Omega Protein Corporation
    • 6.4.3 The Archer Daniels Midland Company
    • 6.4.4 Corbion N.V.
    • 6.4.5 BASF SE
    • 6.4.6 Pelagia AS
    • 6.4.7 Golden Omega
    • 6.4.8 Novotech Nutraceuticals, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS